UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037079
Receipt number R000042251
Scientific Title The effect of high-protein nutrition in the ICU patients.
Date of disclosure of the study information 2019/06/16
Last modified on 2019/06/16 09:15:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of high-protein nutrition in the ICU patients.

Acronym

The effect of high-protein nutrition in the ICU patients.

Scientific Title

The effect of high-protein nutrition in the ICU patients.

Scientific Title:Acronym

The effect of high-protein nutrition in the ICU patients.

Region

Japan


Condition

Condition

sepsis,burn,trauma,hypothermia,hyperthermia,brain injury,herat failure,renal failure,pancreatitis,surgical

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Cardiology Pneumology Endocrinology and Metabolism
Hematology and clinical oncology Nephrology Neurology
Clinical immunology Infectious disease Geriatrics
Surgery in general Gastrointestinal surgery Hepato-biliary-pancreatic surgery
Vascular surgery Chest surgery Endocrine surgery
Breast surgery Obstetrics and Gynecology Oto-rhino-laryngology
Orthopedics Urology Neurosurgery
Cardiovascular surgery Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To survey whether high-protein nutrition effects in infection in the ICU.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Infection rate in the ICU.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Food

Interventions/Control_1

From the first day of nutrition initiation, continuous administration of 10-20 ml / h of peptamintense as tube feeding In combination, the infusion of amipalene 400ml ~ 1000ml body weight adjustment

Interventions/Control_2

From the first day of nutrition initiation, continuous administration of 10-20 ml / h of peptamintense as tube feeding Increase the volume by 10 ml / h every day.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

over 3 days ventilation and over 7 days starvation

Key exclusion criteria

maintainance dialysis,BMI<18,severe malnutrition

Target sample size

104


Research contact person

Name of lead principal investigator

1st name Ginga
Middle name
Last name Suzuki

Organization

Toho University Omori Medical Center

Division name

Critical Care Center

Zip code

143-8541

Address

6-11-1 Omori-Nishi, Ota-ku, Tokyo, Japan

TEL

0337624151

Email

ginga.suzuki@med.toho-u.ac.jp


Public contact

Name of contact person

1st name Ginga
Middle name
Last name Suzuki

Organization

Toho University Omori Medical Center

Division name

Critical Care Center

Zip code

143-8541

Address

6-11-1 Omori-Nishi, Ota-ku, Tokyo, Japan

TEL

0337624151

Homepage URL


Email

ginga.suzuki@med.toho-u.ac.jp


Sponsor or person

Institute

Toho University Omori Medical Center

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toho University Omori Medical Center

Address

6-11-1, Omori-Nishi, Ota-ku, Tokyo, Japan

Tel

0337624151

Email

ginga.suzuki@med.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 06 Month 15 Day

Date of IRB

2018 Year 02 Month 22 Day

Anticipated trial start date

2019 Year 06 Month 16 Day

Last follow-up date

2022 Year 06 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 06 Month 16 Day

Last modified on

2019 Year 06 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042251


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name